Vaccine Delivery System Engineers design, develop, and refine the tools and technologies used to administer vaccines efficiently and safely across diverse settings. Their innovations span from conventional syringes and auto-disable injectors to advanced solutions like microneedle patches, jet injectors, and oral or nasal delivery systems. Their designs prioritize accurate dosing, sterile conditions, ease of operation, convenient transport, and adherence to cold chain standards. These systems must work reliably in both high-tech facilities and remote or resource-limited environments, making thoughtful design and rigorous testing critical to their success.
These engineers also collaborate with manufacturers, public health teams, and logistics specialists to ensure vaccine delivery systems are scalable, cost-effective, and ready for real-world deployment. They test materials for durability, design packaging to protect vaccine integrity, and optimize devices for mass immunization efforts. They play a key role in cutting down vaccine wastage, preventing errors during administration, and enhancing vaccine access for marginalized populations. During global health emergencies, such as pandemics, their designs enable rapid and widespread vaccine deployment. As immunization strategies evolve, Vaccine Delivery System Engineers continue to innovate, supporting safer, more efficient vaccine access worldwide. Their contributions are vital in overcoming logistical challenges and ensuring that life-saving vaccines reach every corner of the globe. Through continuous research and development, they help build a healthier future for all communities.
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Post COVID-19 syndrome is associated with sex and severity of first COVID-19 episode in Honduras
Manuel Antonio Sierra Santos, Central American Technological University, Honduras
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : Development of a platform UPLC-CAD method for high-throughput lipid quantitation and characterization in novel mRNA LNPs
Janet Muzulu, Sanofi, United States
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom